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Richard T Williams1, Alice L Yu1,2,3, Mitchell B Diccianni1, Emmanuel A Theodorakis4 and Ayse Batova4*Erratum
In the original publication of this manuscript [1], Figure 1
Panel C shows three flow cytometry plots. All values re-
ported in the figure are correct, but a duplicate of the EA
plot was mistakenly used for the Vincristine plot. This
mistake did not affect our results or discussion as the text
refers to the correct experimental values. The corrected
Figure 1 is shown below. We apologize for any confusion
this may have caused.
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Figure 1 Induction of cell death by EA in A498 RCC cells. A498 cells were treated with EA at 50 and 100 nM. Control cells received 0.1%
DMSO (vehicle). All conditions were performed in triplicate. Cells were then incubated with additions for 24 or 48 h before measuring viability
using the PrestoBlue® assay (A). A498 cells were treated with 100 nM EA or vehicle for 24 and 45 h durations. Apoptosis was determined by
measuring cytoplasmic histone-associated-DNA-fragments using the Cell Death Detection ELISAPLUS assay kit (B). A498 cells were treated with
100 nM EA or with 0.1% DMSO (control) for 24 and 46 h. Cells were then trypsinized, washed with ice cold PBS, and stained with Alexa Fluor®
488 annexin V and PI and analyzed by flow cytometry (C).
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